Pro-metastatic NEDD9 regulates individual cell migration via caveolin-1-dependent trafficking of integrins

• Published in: Molecular cancer research Vol. 13; no. 3; pp. 423 - 438
• Main Authors: Kozyulina, Polina Y., Loskutov, Yuriy V., Kozyreva, Varvara K., Rajulapati, Anuradha, Ice, Ryan J., Jones, Brandon. C., Pugacheva, Elena N.
• Format: Journal Article
• Language: English
• Published: 15.10.2014
• DOI: 10.1158/1541-7786.MCR-14-0353
• ISSN: 1541-7786

The dissemination of tumor cells relies on efficient cell adhesion and migration, which in turn depends upon endocytic trafficking of integrins. In the current work, it was found that depletion of pro-metastatic protein, NEDD9, in breast cancer (BC) cells results in a significant decrease in individual cell migration due to impaired trafficking of ligand-bound integrins. NEDD9 deficiency does not affect the expression or internalization of integrins but heightens caveolae-dependent trafficking of ligand-bound integrins to early endosomes. Increase in mobility of ligand-bound integrins is concomitant with an increase in tyrosine phosphorylation of caveolin-1 (CAV1) and volume of CAV1-vesicles. NEDD9 directly binds to CAV1 and co-localizes within CAV1 vesicles. In the absence of NEDD9, the trafficking of ligand-bound integrins from early to late endosomes is impaired, resulting in a significant decrease in degradation of ligand/integrin complexes and an increase in recycling of ligand-bound integrins from early endosomes back to the plasma membrane without ligand disengagement, thus leading to low adhesion and migration. Re-expression of NEDD9 or decrease in the amount of active, tyrosine 14 phosphorylated (Tyr14) CAV1 in NEDD9 depleted cells rescues the integrin trafficking deficiency and restores cellular adhesion and migration capacity. Collectively, these findings indicate that NEDD9 orchestrates trafficking of ligand-bound integrins through the attenuation of CAV1 activity.